ECMO SOLUTION
Mespere LifeSciences has developed a completely noninvasive, comprehensive, cardiac and cerebral hemodynamic monitoring platform that meets all 3 key monitoring aspects
MONITORING HIGHLIGHTS
PERFUSION
Venous Oxygen Saturation (SvjO2) -
systemic oxygen consumption
Arterial Oxygen Saturation (SpO2) -
systemic oxygen supply
Regional Tissue Oxygen Saturation (StO2) -
balance between oxygen delivery and consumption for cerebral or lower extremity tissue
​
ADEQUATE FLOW
Cardiac Output (CO) -
native cardiac blood flow
Blood Volume Index (BVI) -
blood volume in regional tissue beneath the sensor
​
CARDIAC FUNCTION
Arterial and Venous Waveform -
pulsatility monitoring
"THE BEST MEASURE OF ADEQUATE SYSTEMIC PERFUSION IS VENOUS SATURATION GREATER THAN 70%"
- ELSO GUIDELINES V1.4
​
​
​
"DURING ECMO REDUCTION, MONITORING CENTRAL VENOUS AND ARTERIAL SATURATION WAS ESSENTIAL"
- J THORAC CARDIOVASC SURG 2011;142:1199
​
​
"CONTINUOUS MONITORING OF CEREBRAL AND LOWER EXTREMITY REGIONAL SATURATION OXYGEN LEVELS COULD PROVIDE INTENSIVISTS WITH EARLY IDENTIFICATION AND INTERVENTION CAPABILITIES VEFORE THE DEVELOPMENT OF IRREVERSIBLE INJURY, AND COULD SERVE AS AN ADJUNCTIVE INDICATOR OF NEUROLOGIC OR LOWER EXTREMITY STATUS IN VA-ECMO PATIENTS"
- ANN TRANSL ED 2020;8(12):792
PRODUCT COMPONENTS -
OPERATING SYSTEM
_JPG.jpg)